Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

INAB

IN8bio (INAB)

IN8bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:INAB
DateTimeSourceHeadlineSymbolCompany
12/23/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
12/23/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
12/23/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
12/23/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
12/23/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
12/23/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
12/23/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
12/23/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
12/10/20246:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INABIN8bio Inc
12/10/20246:00AMGlobeNewswire Inc.IN8bio Reports Continued Progression-Free Survival in Phase 1 Investigator-Sponsored Trial of INB-100 Allogeneic Gamma-Delta T Cells for Leukemias at the 2024 American Society of Hematology Annual MeetingNASDAQ:INABIN8bio Inc
12/02/20246:00AMGlobeNewswire Inc.IN8bio to Present at Noble Capital Markets' Twentieth Annual Emerging Growth Equity ConferenceNASDAQ:INABIN8bio Inc
11/25/20246:09AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INABIN8bio Inc
11/25/20246:00AMGlobeNewswire Inc.IN8bio Reports Continued Durable Remissions in Phase 1 Trial of INB-200 in Plenary Oral Presentation at the Society for Neuro-Oncology (SNO) Annual MeetingNASDAQ:INABIN8bio Inc
11/12/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:INABIN8bio Inc
11/12/20243:45PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:INABIN8bio Inc
11/12/20243:33PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INABIN8bio Inc
11/12/20243:26PMGlobeNewswire Inc.IN8bio Reports Third Quarter 2024 Financial Results and Recent Corporate HighlightsNASDAQ:INABIN8bio Inc
11/12/20246:00AMGlobeNewswire Inc.IN8bio Announces Plenary Oral Presentation at the 2024 Society for Neuro-Oncology (SNO) Annual MeetingNASDAQ:INABIN8bio Inc
11/05/20248:00AMGlobeNewswire Inc.IN8bio Announces Upcoming Presentation at the 2024 American Society of Hematology (ASH) Annual MeetingNASDAQ:INABIN8bio Inc
11/04/20243:31PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:INABIN8bio Inc
10/15/20243:04PMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:INABIN8bio Inc
10/11/20245:13PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
10/08/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
10/08/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
10/08/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
10/01/20243:59PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INABIN8bio Inc
10/01/20247:00AMGlobeNewswire Inc.IN8bio Announces Pricing of $12.4 Million Private PlacementNASDAQ:INABIN8bio Inc
09/11/20243:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INABIN8bio Inc
09/06/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INABIN8bio Inc
09/05/20243:35PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
 Showing the most relevant articles for your search:NASDAQ:INAB

Your Recent History

Delayed Upgrade Clock